Pradaxa Litigation Consolidated in Federal Court

Mass torts — cases in which a large number of individuals suffer harm due to a single instance of negligence — present numerous legal and administrative issues. In order to handle these cases quickly, efficiently and fairly, courts must be ready to adapt by creating systems that promote the uniform and equitable resolution of such claims. The current flood of Pradaxa® litigation is no exception.

Since the FDA issued its warning regarding Pradaxa bleeding risks in December of 2011, a flood of claims have flowed into federal courts across the nation from individual patients and their families who suffered harm due to the drug’s numerous side effects. More than 200 deaths have already been documented and Pradaxa lawyers expect as many as 500 more claims could surface in the near future. As a result, on August 8 the United States Judicial Panel on Multidistrict Litigation ordered all federal Pradaxa lawsuits consolidated into a single action in the United States District Court for the Southern District of Illinois. The Honorable Judge David Herndon presides over this case, entitled In re Pradaxa Product Liability Litigation, MDL No. 2385. A recent order issued by Judge Herndon notes that as of July 25, there were 36 substantially similar Pradaxa cases pending across 14 separate federal judicial districts.

If you or a family member has been injured by Pradaxa side effects, an experienced products liability lawyer at Phillips Law Offices can explain how this recent development affects your rights and what you need to do to start the process of receiving fair compensation.

A Concerning Letter from Johnson & Johnson: TVM and Your Safety

As far back as 2007, Johnson & Johnson had been warned by the Food and Drug Administration (FDA) to discontinue marketing its Gynecare Prolift® transvaginal mesh (TVM) implant. The vaginal mesh is a device used to treat stress incontinence. Women who have this condition must contend with involuntarily bladder leakage brought about by weak uterine wall muscles. The urine discharge usually occurs when affected women sneeze, laugh or engage in a similar activity that uses these muscles in the body. Several manufacturers in addition to Johnson & Johnson have created vaginal meshes that have had serious side effects for women.

Continuing sale in spite of FDA warning

When Johnson & Johnson received the letter of reprimand from the FDA, it chose to ignore it and continued to sell these defective products for another nine months. When the company did finally discontinue producing and selling the Gynecare Prolift vaginal mesh implant, it was due to declining profits and not concern over women’s health risks. Unfortunately, the FDA lacked the power to sanction Johnson & Johnson for deliberately defying the mandates of its reprimand. However, the FDA did issue a warning to all users of the transvaginal mesh in June of 2011. This warning was prompted by complaints about numerous other manufacturers and different types of mesh slings.

Phillips Law Offices in Chicago is available to evaluate your claim if you have been injured by a defective transvaginal mesh product. There are several possibilities for claims, including manufacturing and design defects, failure by manufacturers and doctors to warn women of the risks, and more. Our team of experienced medical malpractice lawyers focuses on TVM cases, and we thoroughly research the facts in your case in order to determine whether a product liability lawsuit can be filed on your behalf. It is our goal to get you the compensation you need to cope with added medical expenses and unnecessary pain and suffering.

J&J Takes A Fall: Can the Public Put Their Trust in Major Pharmaceutical Companies?

For decades, Johnson & Johnson has been a corporate pillar in the pharmaceutical industry. After being hit with multiple product liability lawsuits, it appears that the company’s rock-solid foundation is crumbling. Although Johnson & Johnson grosses more than $65 billion annually, public confidence is dwindling. Recently, the company set aside $600 million to pay a massive fine. Media outlets report that the funds will cover settlements on multiple lawsuits. These suits were related to improperly marketing several pharmaceuticals and for bribing officials overseas.

Legal actions ongoing

In court, J&J is battling lawsuits regarding the antipsychotic medication Risperdal®. The company was sued for failing to publish information about the drug’s risks. In April 2012, the judge handling the case rendered a $1.1 billion verdict. A J&J spokeswoman said that the company would be appealing the ruling or seeking a new trial. On top of this massive award, J&J is facing lawsuits in other states. Judges for two of these cases ordered the company to pay nearly $600 million for similar allegations regarding Risperdal. J&J also paid $158 million to settle a Risperdal case in another state.

Johnson & Johnson is also facing lawsuits related to the medications Invega® and Natrecor®, which the company allegedly marketed for unapproved uses. Amid this never-ending stream of lawsuits, J&J has been charged with distributing kickbacks to artificially increase the sales of Risperdal to nursing home patients. If these allegations are true, Johnson & Johnson will be facing more penalties. The company’s new CEO, who was hired in late April 2012, has said publicly that the company is attempting to restore its image and to boost the confidence of consumers and investors.

These judgments should warn patients in Illinois who are currently taking any of these medications. Patients should discuss the potential risks with their doctor. If you believe you have been injured by a Johnson & Johnson medication, call the experienced medical product liability attorneys at the Phillips Law Offices in Chicago.

Holding Pharmaceutical Companies Responsible for Putting Patients at Risk

Pradaxa® was first introduced as a prescription drug in October of 2010. It is a blood thinner that is prescribed to patients with atrial fibrillation. This condition causes an irregular heartbeat in patients and puts them at increased risk for stroke and blood clots. Just 14 months after the Food and Drug Administration (FDA) approved Pradaxa, it issued a warning statement about its dangers to doctors and patients. The FDA warning came in response to the numerous reports of serious side effects, including:

  • Coughing up blood
  • Dizziness
  • Feeling lethargic
  • Headaches
  • Vomiting blood or vomit that has the appearance of coffee grounds
  • Swelling and pain
  • Discolored urine
  • Unexplained bruises

If you or a loved one take Pradaxa and have experienced any of these symptoms, it is important to seek immediate medical attention. After you are stabilized, you may be considering filing a personal injury lawsuit against the makers of Pradaxa or your doctor for not warning you about its dangers. Since you had to seek additional care to treat symptoms brought on by Pradaxa, it is only right to be compensated for it.

The dangerous drug lawyers at Phillips Law Offices have years of experience helping clients across the country obtain their rightful compensation. We determine who is at fault in your medical product liability case and then file a lawsuit on your behalf. These cases can be difficult to prove, but our defective drug lawyers have access to some of the best medical experts in the country. You do not pay attorneys’ fees until we successfully settle your lawsuit. We seek to recover for your medical expenses and time missed from work, both now and in the future. You may also receive a reward for your physical and emotional suffering as a result of taking this dangerous drugs.